insights_auto
Why is BOT down ၅.၅၆%?
Dive Deeperchevron_right
BOT:ASX
Botanix Pharmaceuticals Ltd
၀.၀၁၇ A$
arrow_downward
-၅.၅၆%(-၀.၀၀၁၀၀) 1D
အောက် ၅, GMT+၁၁ ၁၆:၁၀:၀၈ · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOT...
Open
၀.၀၂ A$
High
၀.၀၂ A$
Low
၀.၀၂ A$
Mkt. cap
၄.၂၃ ကုဋေ
Avg. vol.
၆.၄၁ သန်း
Volume
၀.၀၀
52-wk high
၀.၁၇ A$
52-wk low
၀.၀၂ A$
EPS
-၀.၀၃ A$
Shares outstanding
၂၇၆.၁၅ ဋေ
No. of employees
၁၁
Open
၀.၀၂ A$
High
၀.၀၂ A$
Low
၀.၀၂ A$
Mkt. cap
၄.၂၃ ကုဋေ
Avg. vol.
၆.၄၁ သန်း
Volume
၀.၀၀
52-wk high
၀.၁၇ A$
52-wk low
၀.၀၂ A$
EPS
-၀.၀၃ A$
Shares outstanding
၂၇၆.၁၅ ဋေ
No. of employees
၁၁
News stories
From web sources and news partners
Carroll County Mirror-Democrat
·
ပြီးခဲ့သည့် ၁ နာရီ
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RXO Inc. (NYSE – RXO), PTC Inc. (Nasdaq – PTC), Lifecore Biomedical, Inc. (Nasdaq – LFCR), WaFd, Inc. (Nasdaq
Stock Titan
·
ပြီးခဲ့သည့် ၁၀ မိနစ်
Five new hires’ options vest over four years, if they stay
Yahoo Finance
·
ပြီးခဲ့သည့် ၄၁ မိနစ်
MRNA Stock Soars Ahead Of Slated Return To Nasdaq-100; Retail Echoes Valuation Concerns
Seeking Alpha
·
ပြီးခဲ့သည့် ၅၉ မိနစ်
Record 72 S&P 500 firms issue positive Q3 earnings guidance - FactSet (SPY:NYSEARCA)
Profile
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
About Botanix Pharmaceuticals Ltd